This site limits showing results to the last 12 months. For full access, subscribe at CustomerGauge.com

NPS Intelligence (beta)

Disclosed NPS & retention by vertical

Verticals  /  Pharma, medtech & health distribution  /  Biotech

Biotech

10
Companies
with a public disclosure
3
Gave a number
a disclosed NPS
—
Median latest NPS
last 3 years
49
Silent
known companies, nothing published

Lighthouse companies

Scantox
Biotech · scantox.com
1NPS · 2026
“Scantox's Employee Net Promoter Score fell sharply from 50 to 1 over three years.”
— reported by medwatch.com · 25 Sep 2026
Latest: medwatch.com
NPS · 1 →
Paradigm Clinical Research
Biotech · paradigmresearch.com
96NPS · 2026
“Paradigm Clinical Research reports net promoter score of 96 and consistent record of meeting enrollment targets.”
— reported by biospace.com · 10 Jun 2026
Latest: biospace.com
NPS · 1 →
VedaBio
Biotech
94NPS · 2026
“VedaBio partner UCP Merchant Medicine reports Net Promoter Score of 94 against an industry average of 71.”
— reported by biospace.com · 1 Sep 2026
Latest: biospace.com
NPS · 1 →

More companies

Number of entries in brackets.

Vertex11Fortrea Holdings Inc.4BioCryst Pharmaceuticals, Inc.1COMPASS Pathways plc1PACIFIC BIOSCIENCES OF CALIFORNIA, INC.1Revvity, Inc.1iSpecimen1

Silent

Companies we know of in biotech that have published nothing on NPS or retention.

AbbVie Inc.
Fortune 500 #73
Amgen Inc.
Fortune 500 #120
Biogen Inc.
Fortune 500 #395
Aclaris Therapeutics, Inc.
Pharmaceutical Biotech
Agenus Inc.
Biotech Immunotherapy
Agios Pharmaceuticals, Inc.
Biotech
Anavex Life Sciences Corp.
Biopharmaceutical Company
Arbutus Biopharma Corporation
Biopharmaceutical Company
Ardelyx, Inc.
Biopharmaceutical
Arrowhead Pharmaceuticals, Inc.
Biopharmaceutical
Arvinas, Inc.
Biotech - Drug Discovery
Aurinia Pharmaceuticals Inc
Biopharmaceutical
Axsome Therapeutics, Inc.
Biopharmaceutical
Beam Therapeutics Inc.
Biotech
Benitec Biopharma Limited
Biopharmaceutical
Bio-Path Holdings, Inc.
Biopharmaceutical
CRISPR Therapeutics AG
Biotech
Charles River Laboratories International, Inc.
Contract Research Organization
DBV Technologies S.A.
Biotech Immunotherapy
Editas Medicine, Inc.
Biotechnology
Emergent Biosolutions, Inc.
Biotech & Pharmaceuticals
Fate Therapeutics, Inc.
Biotech - Cell Therapy
Fortress Biotech, Inc.
Biopharmaceutical
Halozyme Therapeutics, Inc.
Biotechnology
Immunovant, Inc.
Biotech
Incyte Corporation
Biopharmaceutical
Intellia Therapeutics, Inc.
Biotech
Ionis Pharmaceuticals, Inc.
Biotechnology
Iovance Biotherapeutics, Inc.
Biotech
Kura Oncology, Inc.
Biopharmaceutical
Kymera Therapeutics, Inc.
Biotech - Drug Discovery
Lexicon Pharmaceuticals, Inc.
Biotech
MediWound Ltd.
Biopharmaceutical
Nektar Therapeutics
Biopharmaceutical Company
Neurocrine Biosciences, Inc.
Biotechnology
Novavax, Inc.
Biotechnology
PTC Therapeutics, Inc.
Biopharmaceutical
Puma Biotechnology Inc
Biotech & Pharmaceuticals
Redhill Biopharma Ltd.
Biopharmaceutical Company
Repligen Corporation
Biotech
Rocket Pharmaceuticals, Inc.
Biotech
Sarepta Therapeutics, Inc.
Biotech
Summit Therapeutics plc
Biopharmaceutical
Syndax Pharmaceuticals, Inc.
Biopharmaceutical Company
TG Therapeutics, Inc.
Biopharmaceutical Company
Ultragenyx Pharmaceutical Inc.
Biopharmaceutical
Windtree Therapeutics, Inc.
Biopharmaceutical
Xencor, Inc.
Biotech
uniQure N.V.
Biotechnology Company

About these figures

Every figure here was publicly disclosed by the named company: press releases, annual reports, SEC filings, earnings calls and news coverage. Companies tend to publish their NPS when it is good, so these numbers run higher than a true industry average: read them as what leading companies in this vertical say publicly, not as an industry benchmark.

NPS runs from −100 to +100. Retention figures are reported as the company defines them (net revenue retention, gross revenue retention, customer retention rate, churn). Every entry links to its source in the full database.